This conversation covers the personal tragedy that led to advocacy, the evolution of marijuana, the impact of THC, roadside testing, controlled substance classification, medical marijuana misconceptions, marijuana research and FDA approval, and the impact of marijuana legalization. It also addresses the public health and safety concerns, marijuana-related incidents, and the need for advocacy and action. Takeaways * Marijuana's evolution has led to higher THC concentrations * The legal system and testing methods for marijuana are inadequate Chapters * 00:00 Personal Tragedy and Advocacy * 05:54 THC Absorption and Testing * 11:04 Marijuana Classification * 16:23 Medical Marijuana Studies * 21:40 Marijuana Research and FDA Approval * 27:28 Public Health and Safety Our guest today is Dr. Phillip Drum, a veteran clinical pharmacist and educator who has spent the last 13 years at the intersection of science and advocacy. From managing hospital pharmacy programs to training Drug Recognition Experts and advising the California Governor’s office, Dr. Drum is a recognized authority on the impact of marijuana on our roads. He was the sole pharmacist invited to present at a landmark DEA hearing, and he’s here to give us the clinical facts on marijuana today. Take action today and write to the administration: mailto:president@whitehouse.gov Please ask him NOT to reclassify marijuana from a CS1 to a CSIII.  His reason for moving it to a CSIII was because he said that it could be studied more.  Please let him know that since 1985 there have been 11,309 studies done to the tune of 4.7 billion dollars of taxpayer money and as a result, not one FDA approval was given for marijuana or cannabis. As a citizen, you urge him to leave marijuana as a controlled substance (CS) I. For more information read: The Attacker smoked Cannabis by Ross Granger

Also watch